Rights and permissions
About this article
Cite this article
Mesalamine dosage affects QOL in Crohn's disease. Pharmacoecon. Outcomes News 31, 14 (1995). https://doi.org/10.1007/BF03272856
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03272856